Dupilumab efficacy and safety in patients with asthma and blood eosinophils >= 500 cells.mu L-1

Klaus F. Rabe; Ian D. Pavord; Mario Castro; Michael E. Wechsler; Nadia Daizadeh; Upender Kapoor; Benjamin Ortiz; Amr Radwan; Robert R. Johnson; Paul J. Rowe; Yamo Deniz; Juby A. Jacob-Nara

doi:10.1183/13993003.02577-2021

Back

Dupilumab efficacy and safety in patients with asthma and blood eosinophils >= 500 cells.mu L-1

Journal article

Open access

Peer reviewed

Dupilumab efficacy and safety in patients with asthma and blood eosinophils >= 500 cells.mu L-1

Klaus F. Rabe, Ian D. Pavord, Mario Castro, Michael E. Wechsler, Nadia Daizadeh, Upender Kapoor, Benjamin Ortiz, Amr Radwan, Robert R. Johnson, Paul J. Rowe, …

The European respiratory journal, Vol.59(6)

01/06/2022

DOI: https://doi.org/10.1183/13993003.02577-2021

PMID: 35487538

Abstract

Life Sciences & Biomedicine

Respiratory System

Science & Technology

Files and links (1)

url

https://doi.org/10.1183/13993003.02577-2021View

Published (Version of record) Open

Metrics

1 Record Views

See more details

Details

Title: Dupilumab efficacy and safety in patients with asthma and blood eosinophils >= 500 cells.mu L-1
Creators - without role: Klaus F. Rabe - German Center for Lung Research
Ian D. Pavord - Oxford BioMedica
Mario Castro - University of Kansas
Michael E. Wechsler - National Jewish Health
Nadia Daizadeh - Sanofi
Upender Kapoor - Sanofi
Benjamin Ortiz - Regeneron
Amr Radwan - Regeneron
Robert R. Johnson - Sanofi, Bridgewater, NJ USA
Paul J. Rowe - Sanofi
Yamo Deniz - Regeneron
Juby A. Jacob-Nara - Sanofi
Publication Details: The European respiratory journal, Vol.59(6)
Publisher: European Respiratory Soc Journals Ltd
Number of pages: 5
Identifiers: 9912547508331
Academic Unit: Al Jouf University
Language: English
Resource Type: Journal article